Progress Toward Measles Elimination — Worldwide, 2000–2022

Details

• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR)
• Personal Author:
  Minta, Anna A. ; Ferrari, Matt ; Antoni, Sebastien ; Portnoy, Allison ; Sbarra, Alyssa ; Lambert, Brian ; Hatcher, Cynthia ; Hsu, Christopher H. ; Ho, Lee Lee ; Steulet, Claudia ; Gacic-Dobo, Marta ; Rota, Paul A. ; Mulders, Mick N. ; Bose, Anindya Sekhar ; Caro, William Perea ; O’Connor, Patrick ; Crowcroft, Natasha S.
• Description:
  Measles is a highly contagious, vaccine-preventable disease that requires high population immunity for transmission to be interrupted. All six World Health Organization regions have committed to eliminating measles; however, no region has achieved and sustained measles elimination. This report describes measles elimination progress during 2000-2022. During 2000-2019, estimated coverage worldwide with the first dose of measles-containing vaccine (MCV) increased from 72% to 86%, then declined to 81% in 2021 during the COVID-19 pandemic, representing the lowest coverage since 2008. In 2022, first-dose MCV coverage increased to 83%. Only one half (72) of 144 countries reporting measles cases achieved the measles surveillance indicator target of two or more discarded cases per 100,000 population in 2022. During 2021-2022, estimated measles cases increased 18%, from 7,802,000 to 9,232,300, and the number of countries experiencing large or disruptive outbreaks increased from 22 to 37. Estimated measles deaths increased 43% during 2021-2022, from 95,000 to 136,200. Nonetheless, an estimated 57 million measles deaths were averted by vaccination during 2000-2022. In 2022, measles vaccination coverage and global surveillance showed some recovery from the COVID-19 pandemic setbacks; however, coverage declined in low-income countries, and globally, years of suboptimal immunization coverage left millions of children unprotected. Urgent reversal of coverage setbacks experienced during the COVID-19 pandemic can be accomplished by renewing efforts to vaccinate all children with 2 MCV doses and strengthening surveillance, thereby preventing outbreaks and accelerating progress toward measles elimination.
• Subjects:
  Full Report
• Keywords:
  Child COVID-19 Disease Eradication Humans Immunization Programs Incidence Infant Measles Measles Vaccine Pandemics Population Surveillance Vaccination

  More +
• Source:
  MMWR Morbidity Mortal Weekly Rep. 72(46):1262-1268
• Series:
  Weekly Report: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.mm7246a3
• ISSN:
  0149-2195 (print) ; 1545-861X (digital)
• Pubmed ID:
  37971951
• Pubmed Central ID:
  PMC10684353
• Document Type:
  Journal Article
• Pages in Document:
  7 pdf pages
• Volume:
  72
• Issue:
  46
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:3d529efbe9cafcf9a33ecd604f246cf575a0ca671a18624db9add3018ee0ad4087bb61ee6b38366a266a4db98b14dcc5fc890b00a80c5f46c15cd6766d905bc5
• Download URL:
  https://stacks.cdc.gov/view/cdc/148631/cdc_148631_DS1.pdf
• File Type:
  [PDF - 157.97 KB ]